Clinical trials: Borderlone Personality Disorder
Borderlone Personality Disorder
Low-Dose Risperidone Treatment for Subjects Suffering From Borderline Personality Disorder
Personality disorders are life-long maladaptive behavioral patterns. Borderline personality disorder (BPD) is the leading personality disorder encountered in clinical settings, often associated with tremendous distress.
- Trial name
- NCT00633802
- Testing
- Risperidone
- Where
- Israel
- Volunteers
- 30 people
- Sponsor
- Tel-Aviv Sourasky Medical Center